BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 17591774)

  • 1. Critical role for the second extracellular loop in the binding of both orthosteric and allosteric G protein-coupled receptor ligands.
    Avlani VA; Gregory KJ; Morton CJ; Parker MW; Sexton PM; Christopoulos A
    J Biol Chem; 2007 Aug; 282(35):25677-86. PubMed ID: 17591774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allosteric small molecules unveil a role of an extracellular E2/transmembrane helix 7 junction for G protein-coupled receptor activation.
    Jäger D; Schmalenbach C; Prilla S; Schrobang J; Kebig A; Sennwitz M; Heller E; Tränkle C; Holzgrabe U; Höltje HD; Mohr K
    J Biol Chem; 2007 Nov; 282(48):34968-76. PubMed ID: 17890226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A model of the human M2 muscarinic acetylcholine receptor.
    Jöhren K; Höltje HD
    J Comput Aided Mol Des; 2002 Nov; 16(11):795-801. PubMed ID: 12825791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a radioligand, [(3)H]LY2119620, to probe the human M(2) and M(4) muscarinic receptor allosteric binding sites.
    Schober DA; Croy CH; Xiao H; Christopoulos A; Felder CC
    Mol Pharmacol; 2014 Jul; 86(1):116-23. PubMed ID: 24807966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of orthosteric and allosteric site mutations in M2 muscarinic acetylcholine receptors that contribute to ligand-selective signaling bias.
    Gregory KJ; Hall NE; Tobin AB; Sexton PM; Christopoulos A
    J Biol Chem; 2010 Mar; 285(10):7459-74. PubMed ID: 20051519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and characterization of orthosteric and allosteric muscarinic M2 acetylcholine receptor ligands by affinity selection-mass spectrometry.
    Whitehurst CE; Nazef N; Annis DA; Hou Y; Murphy DM; Spacciapoli P; Yao Z; Ziebell MR; Cheng CC; Shipps GW; Felsch JS; Lau D; Nash HM
    J Biomol Screen; 2006 Mar; 11(2):194-207. PubMed ID: 16490772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accelerated structure-based design of chemically diverse allosteric modulators of a muscarinic G protein-coupled receptor.
    Miao Y; Goldfeld DA; Moo EV; Sexton PM; Christopoulos A; McCammon JA; Valant C
    Proc Natl Acad Sci U S A; 2016 Sep; 113(38):E5675-84. PubMed ID: 27601651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First principles predictions of the structure and function of g-protein-coupled receptors: validation for bovine rhodopsin.
    Trabanino RJ; Hall SE; Vaidehi N; Floriano WB; Kam VW; Goddard WA
    Biophys J; 2004 Apr; 86(4):1904-21. PubMed ID: 15041637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allosteric modulation in monomers and oligomers of a G protein-coupled receptor.
    Shivnaraine RV; Kelly B; Sankar KS; Redka DS; Han YR; Huang F; Elmslie G; Pinto D; Li Y; Rocheleau JV; Gradinaru CC; Ellis J; Wells JW
    Elife; 2016 May; 5():. PubMed ID: 27151542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical muscarinic allosteric modulation: cooperativity between modulators and their atypical binding topology in muscarinic M2 and M2/M5 chimeric receptors.
    Tränkle C; Dittmann A; Schulz U; Weyand O; Buller S; Jöhren K; Heller E; Birdsall NJ; Holzgrabe U; Ellis J; Höltje HD; Mohr K
    Mol Pharmacol; 2005 Dec; 68(6):1597-610. PubMed ID: 16157694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allostery of atypical modulators at oligomeric G protein-coupled receptors.
    Shivnaraine RV; Kelly B; Elmslie G; Huang XP; Dong YJ; Seidenberg M; Wells JW; Ellis J
    Sci Rep; 2021 Apr; 11(1):9265. PubMed ID: 33927236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of an "Allosteric Site-Impaired" M
    Moo EV; Sexton PM; Christopoulos A; Valant C
    Mol Pharmacol; 2018 Nov; 94(5):1298-1309. PubMed ID: 30213802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based discovery of selective positive allosteric modulators of antagonists for the M
    Korczynska M; Clark MJ; Valant C; Xu J; Moo EV; Albold S; Weiss DR; Torosyan H; Huang W; Kruse AC; Lyda BR; May LT; Baltos JA; Sexton PM; Kobilka BK; Christopoulos A; Shoichet BK; Sunahara RK
    Proc Natl Acad Sci U S A; 2018 Mar; 115(10):E2419-E2428. PubMed ID: 29453275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel mechanism of G protein-coupled receptor functional selectivity. Muscarinic partial agonist McN-A-343 as a bitopic orthosteric/allosteric ligand.
    Valant C; Gregory KJ; Hall NE; Scammells PJ; Lew MJ; Sexton PM; Christopoulos A
    J Biol Chem; 2008 Oct; 283(43):29312-21. PubMed ID: 18723515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allosteric site on muscarinic acetylcholine receptors: identification of two amino acids in the muscarinic M2 receptor that account entirely for the M2/M5 subtype selectivities of some structurally diverse allosteric ligands in N-methylscopolamine-occupied receptors.
    Voigtländer U; Jöhren K; Mohr M; Raasch A; Tränkle C; Buller S; Ellis J; Höltje HD; Mohr K
    Mol Pharmacol; 2003 Jul; 64(1):21-31. PubMed ID: 12815157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist.
    Haga K; Kruse AC; Asada H; Yurugi-Kobayashi T; Shiroishi M; Zhang C; Weis WI; Okada T; Kobilka BK; Haga T; Kobayashi T
    Nature; 2012 Jan; 482(7386):547-51. PubMed ID: 22278061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Conserved Tyrosine Lid Residues in the Activation of the M
    Pham V; Habben Jansen MCC; Thompson G; Heitman LH; Christopoulos A; Thal DM; Valant C
    Mol Pharmacol; 2023 Sep; 104(3):92-104. PubMed ID: 37348914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the novel positive allosteric modulator, LY2119620, at the muscarinic M(2) and M(4) receptors.
    Croy CH; Schober DA; Xiao H; Quets A; Christopoulos A; Felder CC
    Mol Pharmacol; 2014 Jul; 86(1):106-15. PubMed ID: 24807965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allosteric binding sites on muscarinic acetylcholine receptors.
    Wess J
    Mol Pharmacol; 2005 Dec; 68(6):1506-9. PubMed ID: 16183853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allosteric site in M2 acetylcholine receptors: evidence for a major conformational change upon binding of an orthosteric agonist instead of an antagonist.
    Grossmüller M; Antony J; Tränkle C; Holzgrabe U; Mohr K
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Jan; 372(4):267-76. PubMed ID: 16362429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.